Could this be the - plase? Tenecteplase or alteplase for acute ischemic stroke, part 2

Dr. James Braun, Neurosciences Pharmacy Clinical Specialist at SSM Health St. Louis, and Dr. Kyle Hoelting, Senior Manager of Drug Information at Vizient, continue to share their insights on the use of TNK vs Alteplase for treating acute ischemic stroke. They also discuss the nuances of this therapeutic area and share recent work from an expert panel led by Vizient.

 

Guest speakers:
James Braun, PharmD, BCCCP
Neurosciences Pharmacy Clinical Specialist 
SSM Health

 

Kyle Hoelting, PharmD, BCPS
Senior Manager of Drug Information 
Vizient

 

Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence

 

Show Notes:

[00:30-3:59] Medication safety risks associated with thrombolytics

[04:00-4:42] Using one drug over another

[04:43-6:48] How frontline pharmacy staff can utilize this information

[06:49-11:44] What Vizient can add to the discussion

[11:45-11:55] When report will be released

 

Links | Resources:

Tenecteplase vs alteplase in acute ischemic stroke: Vizient expert panel

Verified Rx: Evidenced based medicine Click here

Verified Rx: Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes Click here

Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 1 Click here

Verified Rx: Information overload: tips and tricks for staying on top of the literature, part 2 Click here

 

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed